A
Akari Therapeutics (AKTX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Akari Therapeutics (AKTX)
Akari Therapeutics, Plc is a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases. The Company's lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activati... Read more
- USD0.95
- USD0.96
- USD0.91
- USD4.40
- -21.80%
- --
- 12.00k
- 25.19k
- 23M
- 0.85
- -56.50%
Stock News
6 hours ago
Fidelity Small Cap Index Fund Q4 2024 Review
SeekingAlpha
yesterday
Jim Cramer: The White House should change its messaging
CNBC
yesterday
What happens to gift cards when a chain like Joann or Dollar General closes stores? Here’s what shoppers can do.
MarketWatch
yesterday
Almonds, whiskey, auto parts: EU's retaliatory tariffs set up these U.S. states and local products as the biggest losers
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
